Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Observational Study of Non-small Cell Lung Cancer Patients for Development and Validation of Computational Method for Multi-omics-based Neoantigen Prediction and Biomarkers for Immunotherapy Response Evaluation

NCT04923802 is registered in ClinicalTrials.gov with GeneCast Biotechnology Co., Ltd. as lead sponsor.

NCT NCT04923802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04923802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Observational Study of Non-small Cell Lung Cancer Patients for Development and Validation of Computational Method for Multi-omics-based Neoantigen Prediction and Biomarkers for Immunotherapy Response Evaluation
Lead sponsor
GeneCast Biotechnology Co., Ltd.
Phase
Observational
Overall status
Terminated
Start date
June 24, 2021
Completion date
December 31, 2021
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker, neoantigen, next-generation sequencing, non-small cell lung cancer